Norges Bank Selecta Biosciences Inc Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$1.23 - $3.31 $1.09 Million - $2.92 Million	883,000 New	883,000 $1.09 Million
Q3 2021 Nov 14, 2022	BUY	$3.36 - $4.62 $333,984 - $459,228	99,400 New	99,400 $414,000
Q3 2021 Nov 05, 2021	SELL	$3.36 - $4.62 $1.57 Million - $2.16 Million	-467,800 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$2.82 - $5.01 $1.32 Million - $2.34 Million	467,800 New	467,800 $1.96 Million
Q2 2021 Aug 10, 2021	SELL	$2.82 - $5.01 $683,004 - $1.21 Million	-242,200 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$2.92 - $5.07 $707,224 - $1.23 Million	242,200 New	242,200 $1.1 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.